Showing results (1821-1830 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|November 24, 1999
Antibody production without animalsB M StadlerDevelopments in Biological Standardization|November 24, 1999
Poultry vaccines: an analysis of the animal trials required for vaccine testing and the way to reduce or refine these testsC Jungbäck, B Küchler, E M SchirkDevelopments in Biological Standardization|November 24, 1999
Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccinesC Canthaboo, D Xing, M CorbelDevelopments in Biological Standardization|November 24, 1999
Detection of endotoxins and other pyrogens using human whole bloodS Fennrich, M Fischer, T Hartung, et al.Developments in Biological Standardization|January 1, 1975
Effect of neuraminidase on potency of inactivated influenza virus vaccines in miceE Reichert, R MaulerDevelopments in Biological Standardization|January 1, 1975
Contribution to the standardization of influenza neuraminidase inhibition tests, based on enzyme- antienzyme kinetic studiesU Siekmann, H J Schoop, E KuwertDevelopments in Biological Standardization|January 1, 1979
Cost-benefit analysis of BCG-vaccination in AustriaF Ambrosch, H Klima, G WiedermannDevelopments in Biological Standardization|January 1, 1990
Quality control of anti human CD3 and CD4 monoclonal antibodiesM F Leerling, L M Vaessen, C H Reubsaet, et al.Developments in Biological Standardization|January 1, 1990
Refocusing the immune system to react with human tumors by targeting human lymphocytes with bispecific antibodiesM A Garrido, M J Valdayo, D F Winkler, et al.Developments in Biological Standardization|January 1, 1990
Characterization of human anti-cytomegalovirus monoclonal antibody as biologicsY Masuho, Y Matsumoto, T Tomiyama, et al.Pageof 220